News

According to an article in the January issue of the ACR Bulletin, the ACR recently donated a one-of-kind film of Marie Curie receiving the ACR Gold Medal in 1931 to the Curie Museum in Paris. Famous for the discovery of polonium and radium, Curie was recognized by the ACR for her significant contributions to the field of radiology.

Time January 21, 2013
Home
News

Molecular Breast Imaging (MBI), also known as Breast-Specific Gamma Imaging (BSGI), is a procedure that is able to detect breast cancers missed by mammography and ultrasound, particularly in women with dense breasts. The MBI procedure is now available in hundreds of breast centers nationwide and is commonly utilized as a tool along with mammography and ultrasound to help in the diagnosis of breast cancer. Although the radiation dose associated with this procedure is already low enough to be used in select cases, new research is being conducted to find ways to reduce the dose further so that MBI may be used in annual breast cancer screening for high-risk women with dense breast tissue. The latest results from this research were presented at the Chicago International Breast Course in October by Marcela Bohm-Velez, M.D., the principal investigator of an ongoing trial at Weinstein Imaging Associates in Pittsburgh, Pa.

Time January 21, 2013
Home
News

GE Healthcare announced that it has filed a supplemental new drug application (sNDA) that will allow the company to manufacture Optison (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), within its own facility. Optison is a contrast agent that may improve the visualization of the left ventricular border — an area of the heart that is critical to see in order to assess and diagnose certain heart diseases. Upon approval, GE Healthcare will provide supply of Optison to the U.S. market from its manufacturing facility in Oslo, becoming the only contrast media manufacturer to supply its own stock for the United States.

Time January 18, 2013
Home
Technology

Agfa HealthCare previewed version 2 of its Impax Business Intelligence solution to the U.S. market at the 98th annual meeting of the Radiological Society of North America in November 2012.

Time January 18, 2013
Home
News

At the 98th annual meeting of the Radiological Society of North America (RSNA) in November 2012, Siemens Healthcare demonstrated continued commitment to its Agenda 2013 global initiative by previewing several works-in-progress imaging systems.

Time January 18, 2013
Home
News

Testing of a compact cancer treatment technology from ProTom International Inc. has demonstrated that the system achieves its design specification: delivering high-energy protons to isocenter at a beam intensity sufficient for standard clinical practice.

Time January 18, 2013
Home
Feature

Business and technology analyst Ovum has published three “Trends to Watch" reports on cloud computing and reveals that 2013 will see cloud computing continue to grow rapidly.

Time January 18, 2013
Home
Technology

Mach 7 Technologies unveiled the latest version of its enterprise clinical imaging platform, Keystone Suite, at the 98th annual meeting of the Radiological Society of North America (RSNA) in November 2012.

Time January 17, 2013
Home
News

PenRad’s mammography information system (MIS) has been named the Category Leader in the “2012 Best in KLAS Awards: Software and Services” report for MIS technology for the fifth consecutive year by KLAS. KLAS rankings are based on product quality, ease-of-use and price, as well as customer support according to evaluations given by system users. Since KLAS began analyzing the MIS market in 2008, PenRad MIS has won the Category Leader each year consecutively.

Time January 17, 2013
Home
News

Eli Lilly and Company and Avid Radiopharmaceuticals, Inc., a wholly owned subsidiary of Lilly, announced today that Amyvid (Florbetapir F 18 Injection) has received marketing authorization from the European Commission as a diagnostic radiopharmaceutical indicated for Positron Emission Tomography (PET) imaging of beta-amyloid neuritic plaque density in the brains of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive impairment. Amyvid should be used in conjunction with a clinical evaluation.[1]

Time January 17, 2013
Home
News

GSI Group Inc., a leading supplier of laser-based solutions, precision motion and optical technologies to global industrial, medical, electronics and scientific markets, announced that it has acquired NDS Surgical Imaging (NDS), a San Jose, Calif.-based global leader in surgical and radiology displays and related peripherals, for $82.5 million in cash, subject to customary closing adjustments.

Time January 17, 2013
Home
News

GE Healthcare introduced an expansion of the line of Caring Magnetic Resonance (MR) Suites, built by PDC, that now includes designs specific to GE’s Extremity Optima 430s MR scanner.

Time January 16, 2013
Home
Technology

DICOM Grid, a global provider of cloud-based medical image exchange solutions, recently launched its next generation clinical viewer. This latest release enables the easy access and viewing of complex medical imaging data and associated reporting from any browser-based device or iPad.

Time January 16, 2013
Home
News

Molecular breast imaging company Gamma Medica, Inc. is expanding the capabilities of its LumaGEM Molecular Breast Imaging (MBI) System with a biopsy accessory. Gamma Medica’s technology clearly lights up tumors, even those obscured by dense breast tissue. This new LumaGUIDE hardware and software package, currently a work-in-progress, will allow physicians to precisely identify and biopsy suspicious lesions. The new procedure is quick (about half the time of an MRI-guided biopsy), easy-to-use, and streamlined.

Time January 16, 2013
Home
News

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, announced the completion of a study of its novel radiopharmaceutical NAV4694 as a biomarker for visual detection and quantification of cerebral ?-amyloid in diagnosing Alzheimer’s disease (AD). The study was designed and conducted by Navidea’s partner, AstraZeneca, to assess the effects of various mass amounts of AZD4694 (NAV4694) on safety and the efficacy of positron emission tomography (PET) scanning in subjects with AD and in healthy volunteers (HVs). Evaluations were completed on the effects of two mass doses of the radioligand on binding parameters and overall image quality. These endpoints are typical and important requirements of drug registration dossiers filed with regulatory authorities for approval of diagnostic agents.

Time January 16, 2013
Home
Feature

The number of students entering radiography educational programs decreased in 2012, according to the latest American Society of Radiologic Technologists (ASRT) Enrollment Snapshot of Radiography, Radiation Therapy and Nuclear Medicine Technology Programs.

Time January 16, 2013
Home
Feature

The American Medical Association (AMA) submitted formal comments to the Office of the National Coordinator for Health Information Technology (ONC) on the Health IT Policy Committee’s proposal for Stage 3 of the Medicare/Medicaid meaningful use electronic health record (EHR) program requirements.

Time January 16, 2013
Home
Technology

Lantheus Medical Imaging Inc. has added a low-enriched uranium (LEU) TechneLite (technetium Tc 99m Generator) generator to the its nuclear imaging product portfolio. Lantheus’ LEU TechneLite generator is the first technetium-99m (Tc-99m) generator in the United States that contains molybdenum-99 (Mo-99) produced from at least 95 percent LEU. With greater access to LEU Mo-99 through its supply chain diversification strategy, Lantheus can now move closer to its goal of eventually eliminating Highly Enriched Uranium (HEU)-sourced Mo-99 from its supply chain. Lantheus’ first LEU TechneLite generator was shipped on Jan. 7, 2013.

Time January 16, 2013
Home
News

DR Systems, a leading independent provider of enterprise-wide medical imaging and information systems, announced that the United States Patent and Trademark Office (USPTO) has issued to the company a new patent, relating to a system and method for viewing medical images at full resolution.

Time January 15, 2013
Home
News

Advanced Radiation Therapy (ART), manufacturer of the AccuBoost System for radiation therapy of partial breast and Elekta a global leader in cancer management systems and software, announced today that they have executed an agreement whereby ART acquires the assets of all AccuBoost installations held by Elekta, its worldwide distribution partner. As part of the transaction, ART has purchased the assets and the operating agreements for more than 20 installations in the U.S. The transaction is designed to enable both companies to focus on their core competencies, and serves AccuBoost user groups by allowing ART to increase its support to these installations.

Time January 15, 2013
Home
Subscribe Now